New AIDS Drug Likely to Fall Short of 2003 Demand

Important note: Information in this article was accurate in 2002. The state of the art may have changed since the publication date.

New AIDS Drug Likely to Fall Short of 2003 Demand

Reuters (12.19.02) - Thursday, December 19, 2002

A new AIDS drug will be available to only about 15,000 patients by the end of 2003. Roche Holding AG, a Swiss healthcare group, said its manufacturing plant in Boulder, Col. has been working to meet the challenges to making the complex drug Fuzeon, but initial yields had been lower and cycle times longer than projected. Roche, developing the drug with the Durham, N.C.-based Trimeris Inc., said earlier this year it was targeting 25,000 patients. Injectable Fuzeon is designed for patients resistant to current antiretroviral therapies. Fuzeon is the first of a new group of drugs called fusion inhibitors that are designed to block HIV from entering healthy human immune cells. The companies expect to supply it to a maximum of 32,000 patients by the end of 2004 and 39,000 in 2005.
021219
AD022465

Copyright © 2002 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2002. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2002. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.